A double-staining procedure for the fluorescent treponemal antibody-absorption test, using fluorescein isothiocyanate as a label for the class-specific antihuman globulin and tetramethylrhodamine isothiocyanate as a label for a counterstain reagent, has been described. This method requires the addition of a KP560 barrier filter, with a microscope equipped with vertical illumination, to exclude the rhodamine emission in reading the fluorescein fluorescence. The present study evaluated reversing the dye label for each conjugate in the doublestaining procedure, thus eliminating the need for the KP560 filter. It also considered the possibility of shortening the counterstaining time and compared various methods for preparing antigen slides in an attempt to establish a method that increases the number of treponemes per microscopic field. The results indicate that a rhodamine-labeled class-specific anti-human globulin as a primary stain, and a fluorescein-labeled anti-treponemal globulin as a counterstain, provide an acceptable method for performing the fluorescent treponemal antibody-absorption double-staining procedure. Nonfixed antigen slides were held for 16 days in a desiccator or stored in plastic bags with silica gel for 3 weeks; then, with methanol fixation, they were used satisfactorily in the double-staining procedure. A shortened incubation time for the counterstain allowed more rapid slide processing.
A double-staining procedure for the fluorescent treponemal antibody-absorption test, using fluorescein isothiocyanate as a label for the class-specific antihuman globulin and tetramethylrhodamine isothiocyanate as a label for a counterstain reagent, has been described. This method requires the addition of a KP560 barrier filter, with a microscope equipped with vertical illumination, to exclude the rhodamine emission in reading the fluorescein fluorescence. The present study evaluated reversing the dye label for each conjugate in the doublestaining procedure, thus eliminating the need for the KP560 filter. It also considered the possibility of shortening the counterstaining time and compared various methods for preparing antigen slides in an attempt to establish a method that increases the number of treponemes per microscopic field. The results indicate that a rhodamine-labeled class-specific anti-human globulin as a primary stain, and a fluorescein-labeled anti-treponemal globulin as a counterstain, provide an acceptable method for performing the fluorescent treponemal antibody-absorption double-staining procedure. Nonfixed antigen slides were held for 16 days in a desiccator or stored in plastic bags with silica gel for 3 weeks; then, with methanol fixation, they were used satisfactorily in the double-staining procedure. A shortened incubation time for the counterstain allowed more rapid slide processing.
In an earlier report on the fluorescent treponemal antibody -absorption double -staining (DS) procedure (2), a test using a fluoresceinlabeled, class-specific anti-human globulin as the primary reagent and a rhodamine-labeled antiTreponema pallidum globulin to counterstain the treponemes was described. This procedure provides a method for visualizing all treponemes on microscopic slides without the use of a darkfield condenser when reading FTA-ABS tests with a microscope equipped with vertical illumination.
Although the initial report described the reversal of the dye label for each globulin, the FTA-ABS DS procedure with rhodamine-labeled, class-specific anti-human globulin and fluorescein-labeled anti-treponemal globulin had not been sufficiently evaluated. Our study ex were also used in the DS procedure. The sera for preparation of controls in the DS procedure and the sera for evaluation of the tests were characterized samples from syphilitic and nonsyphilitic subjects and were obtained through the Venereal Disease Serum Bank, Center for Disease Control. These had been stored at -20°C for 2 or more years. Additional sera from a Public Health Service outpatient clinic, blood banks, and local venereal disease clinics were examined. These sera had been stored at 5°C until examined.
Labeled globulin were the same as previously described (2). Goat anti-Fc fragment of pooled normal human immunoglobulin G and human sera obtained from patients with clinically documented, untreated latent or untreated secondary syphilis were used to prepare the primary and secondary reagents. Each serum was fractionated by diethylaminoethyl-Sephadex, with 0.1 M NaCl-containing 0.05 M boric acid buffer adjusted to pH 8.0 with NaOH. For this study the primary antibody was labeled with tetramethyl-rhodamine isothiocyanate, and the secondary antibody was fluorescein-labeled anti-T. pallidum globulin.
Procedure. Antigen slides were acetone-fixed smears, frozen and stored at -20°C as described in the reference FTA-ABS test. The FTA-ABS DS test was conducted in the following manner: human serum, diluted 1:5 in sorbent, was incubated with T. pallidum antigen for 30 min at 37°C. The slides were rinsed in phosphate-buffered saline. The rhodamine-labeled anti-human immunoglobulin G was added to each smear and allowed to incubate for 30 min at 37°C. The slides were rinsed again in phosphate-buffered saline.
Then the smears were stained with the fluoresceinlabeled human anti-T. pallidum globulin and incubated for 30 min at 37°C. The slides were rinsed a final time in phosphate-buffered saline, and then mounted with glycerine saline, and a cover slip was added.
To evaluate slides prepared by the reference FTA-ABS test procedures (4) with a microscope equipped for vertical illumination, the test control slides were prepared in the conventional manner. The fluorescence intensities obtained on these slides were read first with transmitted illumination, then with vertical illumination. For reading with vertical illumination, the treponemes were first focused by dark-field microscopy, and then the light was positioned for vertical illumination. Fluorescence intensities on each slide were recorded with the following optics: (i) a 10X ocular and a 40x high, dry objective, (il) a 10x ocular and a 40x 1.3 oil objective, (iii) a 6.3x ocular and a 10Ox/1.3 achromatic oil objective.
Several incubation times were selected to consider the effect of shortening the times allowed for counterstaining with the fluorescein-labeled reagent. In addition to the established 30-min incubation period, staining times of 5, 10, and 20 min were chosen. The fluorescein-labeled anti-T. pallidum counterstain was applied to slides previously incubated with absorbed reactive and nonreactive control sera, phosphatebuffered saline, and sorbent in the first incubation period, followed by rhodamine-labeled anti-human globulin in the second step. The smears were incubated at 37°C for the given times.
To examine the different methods of antigen fixation, the antigen slides were prepared in the following ways. (i) Smears prepared from rehydrated antigen were fixed with acetone for 10 min, air dried, and stored at -20°C until used (4). (ii) On the day of use, smears prepared from rehydrated antigen were fixed with 10% methanol for 20 s, blotted dry, and allowed to air dry (4). (ni) Smears prepared from rehydrated antigen were stored in a room-temperature desiccator, and on the day of use they were fixed with 10% methanol for 20 s, blotted dry, and allowed to air dry (5) .
The FTA-ABS DS procedure was performed as described but with a 20-min counterstain incubation time. To determine the effectiveness of the method of storage and fixation, the average number was obtained by counting the treponemes on 10 microscopic fields.
To eliminate repeated opening of the desiccator and the consequent deterioration of the antigen, smears prepared from rehydrated antigen were stored in plastic bags containing silica gel (Davison Chemical Co., Baltimore, Md.) and held at 5 or -20°C until ready to use. The slides were then fixed with 10% methanol as described above. Microscope. All slides were observed with a Leitz Ortholux II microscope equipped with a Ploemopak multi-wavelength fluorescence illumination and an oil dark-field condenser, D1.26-1.40, for transmitted illumination. A high-pressure mercury arc lamp (HBO-200 or HBO-50) was attached to the microscope with a mirror housing reflecting the light from the rightangle position of the lamp into the microscope. A 40X/ 1.30 oil objective and a 10Ox/1.30 achromatic oil objective with a 6.3x ocular were used for observations with vertical illumination; a 40x high, dry objective and a lOx ocular were used for the single-staining FTA-ABS test procedure.
RESULTS
Evaluation. The test results obtained on 175 sera by the single-staining FTA-ABS procedure and the two DS FTA-ABS procedures are shown in Table 1 . The DS procedures appear to be slightly less sensitive in the sera from syphilitic patients, but fewer borderline reactions were obtained in sera from nonsyphilitics.
When single-staining FTA-ABS test control slides were read with transmitted illumination, an acceptable pattern of fluorescence was obtained (Table 2) . When the same slides were read with vertical illumination, unsatisfactory fluorescence was observed with the 10x ocular and 40x high, dry objectives. Fluorescence intensity was increased when the 10x ocular was used with either oil objective; however, with the 40x/1.30 oil objective, a moderate to heavy fluorescent background film was present. The background film was reduced with the 100x/ 1.30 oil objective, and fluorescence intensity improved with the 6.3x ocular. With these optics, fluorescence intensity was comparable to readings obtained by transmitted illumination. AIthough the presence of treponemes on each slide was verified by dark-field examination, nonreactive smears could not be focused satisfactorily for observation with vertical illumination.
Counterstain time. The optimal counterstaining time of 30 min was verified for the fluorescein-labeled globulin; however, 3+ staining was obtained with a counterstaining time of 10 min. Only the 5-min counterstaining time yielded low staining intensity (Table 3) .
Antigen fixation. Antigen slides fixed with 10% methanol and read with a 6.3x ocular and a 100x oil objective had more treponemes per field (6.7 per 100x field) than acetone-fixed slides (2.2 per 100x field). When the prepared antigen slides that were stored for up to 16 days in a desiccator and fixed with 10% methanol for 30 s on the day of use were examined in the DS By using a rhodamine-labeled anti-human globulin as the primary stain, the need for the KP560 barrier filter was eliminated. This is an advantage since this filter is expensive and difficult to obtain. Rhodamine filters would be required to exclude fluorescein emission; however, this would reduce the cost differential between the two techniques.
Since the purpose of the counterstain is merely to locate the treponemes, a reading of 4+ is not necessary, and by reducing the incubation time for the counterstaining step, the test can be run in a shorter period of time, which makes it more appealing for routine serology. With a counterstaining time of less than 10 min, reduced fluorescence of the treponemes negates any further time-saving benefits. Antigen fixation methods seem to be a matter of preference as far as most laboratories are concerned. By increasing the numbers of treponemes per field, FTA-ABS DS tests can be read faster, since time is saved looking for the treponemes on the slide. Many laboratories prefer acetone-fixed slides because these can be prepared in advance, frozen, and stored at -20°C indefinitely. Methanol-fixed fresh smears provide increased numbers of treponemes per field but have the disadvantage of requiring preparation on the day of the FTA-ABS test (4). Desiccator-stored slides appear to offer an alternative to everyday preparation when using methanol fixation.
We found no problem in the performance of the DS procedure. The adjustment to interpreting rhodamine fluorescence rather than fluorescein fluorescence was not difficult. We recommend the use of the FTA-ABS DS procedure with rhodamine-labeled class-specific anti-human globulin and a fluorescein-labeled human anti-T. pallidum globulin.
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